Antibody to receptor activator of NF-κB ligand ameliorates T cell-mediated periodontal bone resorption

Infection and Immunity

Volumn 79, Issue 2, 2011, Pages 911-917

  Lin, Xiaoping ^a,b   Han, Xiaozhe ^a   Kawai, Toshihisa ^a   Taubman, Martin A ^a  

^a FORSYTH INSTITUTE   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; LIPOPOLYSACCHARIDE; OUTER MEMBRANE PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ALVEOLAR BONE LOSS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CLONE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; FEMALE; GINGIVA; HUMORAL IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ALVEOLAR BONE LOSS; ANIMALS; CELL LINE; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN G; MACROPHAGES; MICE; OSTEOCLASTS; PASTEURELLACEAE; RABBITS; RATS; RATS, INBRED STRAINS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; T-LYMPHOCYTES;

EID: 79251502922     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00944-10     Document Type: Article

References (34)

1. Anand, D. V., A. Lahiri, E. Lim, D. Hopkins, and R. Corder. 2006. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J. Am. Coll. Cardiol. 47:1850-1857.
2. Anderson, D. M., et al. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
3. Bone, H. G., et al. 2008. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. J. Clin. Endocrinol. Metab. 93: 2149-2157.
4. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60-66.
5. Crotti, T., et al. 2003. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J. Periodontal Res. 38:380-387.
6. Ebersole, J. L., et al. 1984. Serological identification of oral Bacteroides spp. by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 19:639-644.
7. Hamdy, N. A. 2008. Denosumab: RANKL inhibition in the management of bone loss. Drugs Today (Barcelona) 44:7-21.
8. Han, X., T. Kawai, J. W. Eastcott, and M. A. Taubman. 2006. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J. Immunol. 176:625-631.
9. Han, X., T. Kawai, and M. A. Taubman. 2007. Interference with immune-cell-mediated bone resorption in periodontal disease. Periodontol. 2000 45: 76-94.
10. Ikeda, F., et al. 2004. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114: 475-484.
11. Katz, J., K. P. Black, and S. M. Michalek. 1999. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model. Infect. Immun. 67:4352-4359.
12. Kawai, T., et al. 2000. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J. Immunol. 164:2102-2109. (Pubitemid 30108769)
13. Kawai, T., et al. 2006. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 169:987-998.
14. Kawai, T., et al. 2007. Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent periodontal bone resorption in a mouse model. Oral Microbiol. Immunol. 22:208-215.
15. Kawai, T., H. Shimauchi, J. W. Eastcott, D. J. Smith, and M. A. Taubman. 1998. Antigen direction of specific T-cell clones into gingival tissues. Immunology 93:11-19.
16. Khosla, S. 2005. Magic bullets to kill nasty osteoclasts. Endocrinology 146: 3233-3234.
17. Kirkwood, K. L., et al. 2007. A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J. Pharmacol. Exp. Ther. 320:56-63.
18. Komatsuzawa, H., et al. 1999. Cloning of the gene encoding the Actinobacillus actinomycetemcomitans serotype b OmpA-like outer membrane protein. Infect. Immun. 67:942-945.
19. Kong, Y. Y., et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
20. Lewiecki, E. M., et al. 2007. Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD. J. Bone Miner. Res. 22:1832-1841.
21. McClung, M. R., et al. 2006. Denosumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 354:821-831.
22. Michalek, S. M., J. Katz, N. K. Childers, M. Martin, and D. F. Balkovetz. 2002. Microbial/host interactions: mechanisms involved in host responses to microbial antigens. Immunol. Res. 26:223-234.
23. Mueller, S. N., et al. 2007. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317:670-674. (Pubitemid 47229967)
24. Perry, M. B., L. L. MacLean, R. Gmur, and M. E. Wilson. 1996. Characterization of the O-polysaccharide structure of lipopolysaccharide from Actinobacillus actinomycetemcomitans serotype b. Infect. Immun. 64:1215-1219.
25. Stachowiak, A. N., Y. Wang, Y. C. Huang, and D. J. Irvine. 2006. Homeostatic lymphoid chemokines synergize with adhesion ligands to trigger T and B lymphocyte chemokinesis. J. Immunol. 177:2340-2348.
26. Taubman, M. A., and T. Kawai. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit. Rev. Oral Biol. Med. 12:125-135.
27. Taubman, M. A., T. Kawai, and X. Han. 2007. The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. J. Clin. Periodontol. 34:367-369.
28. Taubman, M. A., P. Valverde, X. Han, and T. Kawai. 2005. Immune response: the key to bone resorption in periodontal disease. J. Periodontol. 76:2033-2041.
29. Taubman, M. A., H. Yoshie, J. L. Ebersole, D. J. Smith, and C. L. Olson. 1984. Host response in experimental periodontal disease. J. Dent. Res. 63:455-460.
30. Theill, L. E., W. J. Boyle, and J. M. Penninger. 2002. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20:795-823.
31. Valverde, P., T. Kawai, and M. A. Taubman. 2004. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J. Bone Miner. Res. 19:155-164.
32. Wilson, M. E., and R. G. Hamilton. 1995. Immunoglobulin G subclass response of juvenile periodontitis subjects to principal outer membrane proteins of Actinobacillus actinomycetemcomitans. Infect. Immun. 63:1062-1069.
33. Yamashita, K., J. W. Eastcott, M. A. Taubman, D. J. Smith, and D. S. Cox. 1991. Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease. Infect. Immun. 59: 1529-1534.
34. Zadeh, H. H., F. C. Nichols, and K. T. Miyasaki. 1999. The role of the cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis. Periodontol. 2000 20:239-288.